Evidence map›Paper›PMID 40100868›Full record

ArticlePloS one2025

Machine learning for predicting metabolic-associated fatty liver disease including NHHR: a cross-sectional NHANES study.

Liyu Lin, Yirui Xie, Zhuangteng Lin, Cuiyan Lin, Yichun Yang

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. A potential XGBoost Diagnostic Score forFrontiers in immunology · 2025
    Article
  3. Article
  4. Psoas Muscle Index, Systemic Inflammation, and Liver Fibrosis in MAFLD: A Case-Control Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liyu LinThe First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Yirui XieThe First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Zhuangteng LinThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Cuiyan LinGuangzhou Red Cross Hospital, Guangzhou, China.
Yichun YangThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.ORCID 0000-0003-3133-7805

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMetabolic - associated fatty liver disease (MAFLD) is a common hepatic disorder with increasing prevalence, and early detection remains inadequately achieved. This study aims to explore the relationship between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and MAFLD, and to establish a predictive model for MAFLD using NHHR as a key variable.

methodsAll participants were selected from the NHANES cohort, spanning from 2017 to March 2020. Multiple linear regression models were employed to examine the relationship between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and the controlled attenuation parameter (CAP). To explore the non-linear association between NHHR and CAP, smooth curve fitting and restricted cubic splines (RCS) of the adjusted variables were utilized. Subgroup analyses were conducted to identify variations in the relationships between the independent and dependent variables across different populations. Finally, a metabolic - associated fatty liver disease (MAFLD) prediction model was developed using seven machine learning methods, including eXtreme Gradient Boosting (XGBoost), Light Gradient Boosting Machine (LightGBM), Multilayer Perceptron (MLP), Random Forest, Support Vector Machine (SVM), K-Nearest Neighbors (KNN), and logistic regression. The SHAP (SHapley Additive exPlanations) value was employed to interpret the importance of various features.

resultWeighted multiple linear regression models revealed a significant positive correlation between the NHHR and the CAP (Beta =  7.42, 95% CI: 5.35-9.50, P <  0.001). Smooth curve fitting and RCS demonstrated a non-linear relationship between NHHR and CAP. Subgroup analyses indicated that this relationship was more pronounced in females. Among the seven machine learning predictive models incorporating NHHR, the XGBoost algorithm exhibited the highest predictive performance, with an area under the curve (AUC) of 0.828. Furthermore, NHHR was identified as the second most important feature in the SHAP analysis, following body mass index (BMI), highlighting its potential in predicting MAFLD.

conclusionA significant positive correlation was identified between the NHHR and the CAP. The inclusion of NHHR in the XGBoost predictive model for MAFLD demonstrated robust predictive capability, providing a valuable tool for the early detection of MAFLD with considerable clinical application potential.

Indexed as

Cholesterol, HDLFatty LiverMachine LearningNon-alcoholic Fatty Liver DiseaseAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedNutrition SurveysCholesterol, HDL

Identifiers

PMID40100868
PMCPMC11918377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.